Keywords: اینترلوکین 6 (IL-6); cognitive dysfunction; cytokines; interleukin-6 (IL-6); surgery; tocilizumab;
مقالات ISI اینترلوکین 6 (IL-6) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترلوکین 6 (IL-6); Chronic heart failure (CHF); Sheng Mai Yin (SMY); Matrix metalloproteinases (MMPs); Tumor necrosis factor-α (TNF-α); interleukin-6 (IL-6); CA; Captopril administration group; CHF; Chronic heart failure; CHFM; CHF model group; COL-IV; Collagen-IV; CON; C
Keywords: اینترلوکین 6 (IL-6); Tau; Interleukin-6 (IL-6); Obstructive sleep apnea (OSA); Biomarkers; Neurodegeneration; Inflammation;
Keywords: اینترلوکین 6 (IL-6); Physical activity; Mood; Interleukin-6 (IL-6); Tumor necrosis factor alpha (TNF-α); Cytokines; Mental health;
Keywords: اینترلوکین 6 (IL-6); Posttraumatic stress disorder (PTSD); Inflammation; Interleukin-6 (IL-6); Cognitive function;
Keywords: اینترلوکین 6 (IL-6); MSIMI; mental stress induced myocardial ischemia; CAD; coronary artery disease; IL-6; interleukin-6 (IL-6); MCP-1; monocyte chemoattractant protein-1; MMP-9; matrix metallopeptidase 9; HsCRP; high-sensitivity C reactive protein; MI; myocardial infarction;
Keywords: اینترلوکین 6 (IL-6); Major depressive disorder; Bipolar disorder; Cytokine; Ketamine; Interleukin-6 (IL-6); Soluble tumor necrosis factor receptor 1 (sTNFR1);
Keywords: اینترلوکین 6 (IL-6); Pro-inflammatory cytokines; C-reactive protein (CRP); Interleukin-6 (IL-6); Tumor necrosis factor (TNF); Interleukin-1β (IL-1β); Low back pain (LBP);
Keywords: اینترلوکین 6 (IL-6); Mesenchymal stroma; Osteosarcoma; Microenvironment; IL-6; Extracellular vesicles; Metabolites; mesenchymal stromal cells (MSC); osteosarcoma (OS); cancer-associated fibroblasts (CAF); interleukin-6 (IL-6); cancer stem cells (CSC); exosomes (EXO);
Keywords: اینترلوکین 6 (IL-6); Maternal immune activation (MIA); Maternal-placental-fetal axis; Interleukin-6 (IL-6); Placenta; Hindbrain development; Purkinje cells; Autism spectrum disorder (ASD);
Keywords: اینترلوکین 6 (IL-6); IL-6; interleukin-6; ND; normal diet; HFD; high fat diet; FAs; fatty acids; CD36; cluster of differentiation 36; MCP-1; monocyte chemoattractant protein 1; PPARα; peroxisome proliferator-activated receptor α; CPT-1; carnitine palmitoyltransferase 1; End
Keywords: اینترلوکین 6 (IL-6); Interleukin-6 (IL-6); Tumor necrosis factor alpha (TNF-α); Proinflammatory cytokines; Depression; Cognitive Behavioral Therapy (CBT);
Keywords: اینترلوکین 6 (IL-6); Interleukin-6 (IL-6); Metabolic disease; IL-6; interleukin-6; MS; metabolic syndrome; ROS; reactive oxygen species; IFN; interferon; hIL-6; human interleukin-6; SHP-2; Src homology domain-containing protein tyrosine phosphatase-2; IR; insulin resistance;
Keywords: اینترلوکین 6 (IL-6); Interleukin-6 (IL-6); Cytokines; Circadian; Immune; Inflammation; Blood–brain-barrier (BBB); Cerebrospinal fluid (CSF); Sleep; Stress; Neuroimmunology
Keywords: اینترلوکین 6 (IL-6); Persistent inflammation; Smoking; Stress; Cancer survivors; Interleukin-6 (IL-6); Cortisol; Glucocorticoid resistance;
Keywords: اینترلوکین 6 (IL-6); Subjective social status; Inflammation; Interleukin-6 (IL-6); Laboratory stressor;
Keywords: اینترلوکین 6 (IL-6); Interleukin-6 (IL-6); Myeloperoxidase (MPO); Microalbuminuria (MA); Prediabetes
Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients
Keywords: اینترلوکین 6 (IL-6); Epithelial ovarian cancer (EOC); Ascitic fluid; Interleukin-6 (IL-6); Vascular endothelial growth factor (VEGF-A); Diagnostic bio-marker; Prognostic bio-marker; Progression free survival;
Polyriboinosinic-polyribocytidylic acid facilitates interleukin-6, and interleukin-8 secretion in human dermal fibroblasts via the JAK/STAT3 and p38 MAPK signal transduction pathways
Keywords: اینترلوکین 6 (IL-6); Human dermal fibroblasts; PolyI:C; Interleukin-6 (IL-6); Interleukin-8 (IL-8); Wound healing; Cytokine; STAT3, p38 MAPK;
Dibutyryl cAMP- or Interleukin-6-induced astrocytic differentiation enhances mannose binding lectin (MBL)-associated serine protease (MASP)-1/3 expression in C6 glioma cells
Keywords: اینترلوکین 6 (IL-6); Interleukin-6 (IL-6); 2â²-O-Dibutyryl cAMP (dbcAMP); Mannose-binding lectin (MBL)-associated serine proteases (MASP)-1 and 3; C6 glioma cell line; Astrocytic differentiation; Glial fibrillary acidic protein (GFAP); CNS; central nervous system; GBM; gliob
Association of genetic variations in IL-6/IL-6R pathway genes with gastric cancer risk in a Chinese population
Keywords: اینترلوکین 6 (IL-6); IL-6; Interleukin-6; IL-6R; Interleukin-6 receptor; SNPs; Single nucleotide polymorphisms; H. pylori; Helicobacter pylori; HWE; Hardy-Weinberg equilibrium; OR; odds ratios; CI; confidence intervals; Gastric cancer; Interleukin-6 (IL-6); Interleukin-6 rece
Preventive effects of interleukin-6 in lipopolysaccharide/d-galactosamine induced acute liver injury via regulating inflammatory response in hepatic macrophages
Keywords: اینترلوکین 6 (IL-6); Lipopolysaccharide (LPS); Acute liver injury; Interleukin-6 (IL-6); Macrophage; Inflammation;
Association study involving polymorphisms in IL-6, IL-1RA, and CTLA4 genes and rheumatic heart disease in New Zealand population of MÄori and Pacific ancestry
Keywords: اینترلوکین 6 (IL-6); Rheumatic fever; Rheumatic heart disease; Interleukin-6 (IL-6); Interleukin-1 receptor antagonist (IL-1RA); cytotoxic T-lymphocyte associated protein 4 (CTLA4);
TL1A increased IL-6 production on fibroblast-like synoviocytes by preferentially activating TNF receptor 2 in rheumatoid arthritis
Keywords: اینترلوکین 6 (IL-6); TL1A; tumor necrosis factor-like protein 1A; DR3; death receptor 3; RA; rheumatoid arthritis; FLS; fibroblast-like synoviocytes; IL; interleukin; Th17; IL-17-producting helper T cells; DcR3; decoy receptor 3; MMPs; matrix metallo-proteinase; NF-κB; nucle
Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells
Keywords: اینترلوکین 6 (IL-6); Colorectal cancer (CRC); Interleukin-6 (IL-6); Ginsenoside 20(S)-Rh2; Matrix metalloproteinase (MMP); Signal transducer and activator of transcription 3 (STAT3);
Role of interleukin-6 (IL-6) in diagnosis of malignant pleural mesothelioma
Keywords: اینترلوکین 6 (IL-6); Interleukin-6 (IL-6); Mesothelioma; Pleural effusion
Effects of aspirin on expression of iron transport and storage proteins in BV-2 microglial cells
Keywords: اینترلوکین 6 (IL-6); Aspirin (acetylsalicylic acid, ASA); Iron metabolism; Inflammation and lipopolysaccharides (LPS); Transferrin receptor 1 (TfR1); Ferroportin 1 (Fpn1); Tumor necrosis factor-αlpha (TNF-alpha); Interleukin-6 (IL-6); Hepcidin;
Early post-stressor intervention with minocycline, a second-generation tetracycline, attenuates post-traumatic stress response in an animal model of PTSD
Keywords: اینترلوکین 6 (IL-6); Animal model; Post-traumatic stress disorder; Minocycline; Interleukin-1 (IL-1); Interleukin-6 (IL-6); Tumor necrosis factor-α (TNF-α);
Spożywanie piwa i alkoholu etylowego a poziom wybranych interleukin w osoczu u młodych szczurów Wistar
Keywords: اینترلوکین 6 (IL-6); Cytokines; Interleukin-6 (IL-6); Interleukin-10 (IL-10); Beer; Ethyl alcohol; Wistar ratscytokiny; interleukina-6 (IL-6); interleukina-10 (IL-10); alkohol etylowy; piwo; szczury Wistar
Toll-like receptor 4 (TLR4) is correlated with delayed cerebral ischemia (DCI) and poor prognosis in aneurysmal subarachnoid hemorrhage
Keywords: اینترلوکین 6 (IL-6); Aneurysmal subarachnoid hemorrhage (aSAH); Toll-like receptor 4 (TLR4); Tumor necrosis factor-α (TNF-α); Interleukin-6 (IL-6); Peripheral blood mononuclear cells (PBMCs); Delayed cerebral ischemia (DCI); Poor clinical outcome;
The interaction between maternal immune activation and alpha 7 nicotinic acetylcholine receptor in regulating behaviors in the offspring
Keywords: اینترلوکین 6 (IL-6); Maternal immune activation (MIA); Maternal infection; Poly(I:C); Nicotinic acetylcholine receptor alpha 7 subunit (α7AChR, CHRNA7, Chrna7); Choline supplementation; Interleukin-6 (IL-6); Schizophrenia; Autism;
Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse
Keywords: اینترلوکین 6 (IL-6); CC chemokine ligand 2 (CCL2); Chronic relapsing-remitting experimental autoimmune encephalomyelitis (CREAE); Interferon-γ (IFN-γ); Interleukin-6 (IL-6); Multiple sclerosis; Tumor necrosis factor-α (TNF-α);
Cerebrospinal Fluid TNF-α, IL-6, and IL-8 in Children With Bacterial Meningitis
Keywords: اینترلوکین 6 (IL-6); meningitis; cerebrospinal fluid; tumor necrosis factor-alpha (TNF-α); interleukin-6 (IL-6); interleukin-8 (IL-8)
Knockdown of TrkA in cumulus oocyte complexes (COCs) inhibits EGF-induced cumulus expansion by down-regulation of IL-6
Keywords: اینترلوکین 6 (IL-6); NGF; nerve growth factor; TrkA; tyrosine receptor kinase A; COCs; cumulus oocyte complexes; GCs; granulosa cells; CCs; cumulus cells; EGF; epidermal growth factor; CEEFs; oocyte-secreted cumulus expansion-enabling factors; Ptgs2; prostaglandin-endoperoxid
Autocrine production of interleukin-6 confers ovarian cancer cells resistance to tamoxifen via ER isoforms and SRC-1
Keywords: اینترلوکین 6 (IL-6); Interleukin-6 (IL-6); Tamoxifen (TAM) resistance; Estrogen receptor (ER) isoforms; Steroid hormone receptor coactivator (SRC)-1; Ovarian cancer (OVCA);
Serotonin acts as a novel regulator of interleukin-6 secretion in osteocytes through the activation of the 5-HT2B receptor and the ERK1/2 signalling pathway
Keywords: اینترلوکین 6 (IL-6); Serotonin (5-HT); Interleukin-6 (IL-6); Osteocytes; Extracellular signal-regulated kinase 1/2 (ERK1/2);
Up-regulation of interleukin-6 and vascular endothelial growth factor-A in the synovial fluid of temporomandibular joints affected by synovial chondromatosis
Keywords: اینترلوکین 6 (IL-6); Temporomandibular joint; Synovial chondromatosis; Synovitis; Vascular endothelial growth factor-A (VEGF-A); Interleukin-6 (IL-6)
The increased maternal serum levels of IL-6 are associated with the severity and onset of preeclampsia
Keywords: اینترلوکین 6 (IL-6); Interleukin-6 (IL-6); Preeclampsia; Inflammation;
Effect of spinal and general anesthesia on serum concentration of pro-inflammatory and anti-inflammatory cytokines
Keywords: اینترلوکین 6 (IL-6); Spinal anesthesia; General anesthesia; Interleukin-2 (Il-2); Interleukin-6 (IL-6)
Effects of C-reactive protein on adipokines genes expression in 3T3-L1 adipocytes
Keywords: اینترلوکین 6 (IL-6); C-reactive protein (CRP); Adipokines; Tumor necrosis factor-α (TNF-α); Interleukin-6 (IL-6); 3T3-L1 adipocyte
Inflammation and reactivation of latent herpesviruses in older adults
Keywords: اینترلوکین 6 (IL-6); Cytomegalovirus (CMV); Epstein-Barr virus (EBV); C-reactive protein (CRP); Interleukin-6 (IL-6); Aging; Latent reactivation; Immunosenescence;
The Stress-Induced Cytokine Interleukin-6 Decreases the Inhibition/Excitation Ratio in the Rat Temporal Cortex via Trans-Signaling
Keywords: اینترلوکین 6 (IL-6); 2-Br-hexadecanoic acid; postsynaptic; Brefeldin A; dynamin inhibitory peptide; foot-shock; γ-aminobutyric acid (GABA); interleukin-6 (IL-6); lipopolysaccharide (LPS); PI3K/AKT; patch-clamp; stress; gp130; rat; temporal cortex; trans-signaling; wortmannin
C-reactive protein, Interleukin-6, and posttraumatic stress disorder symptomology in urban police officers
Keywords: اینترلوکین 6 (IL-6); Police; Posttraumatic stress disorder (PTSD); C-reactive protein (CRP); Interleukin-6 (IL-6); Inflammatory markers
Distributions of interleukin-6 (IL-6) promoter and metallothionein 2A (MT2A) core promoter region gene polymorphisms and their associations with aging in Turkish population
Keywords: اینترلوکین 6 (IL-6); Interleukin-6 (IL-6); Metallothionein 2A; Gene polymorphism; Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP); Longevity;
RNA Interference Inhibits High Mobility Group Box 1 by Lipopolysaccharide-Activated Murine Macrophage RAW 264.7 Secretion
Keywords: اینترلوکین 6 (IL-6); high mobility group box 1 (HMGB-1); short interfering RNAs (siRNAs); tumor necrosis factor α; (TNF-α); interleukin-6 (IL-6); transforming growth factor β (TGF-β)
Correlations among inflammatory markers in plasma, saliva and oral mucosal transudate in post-menopausal women with past intimate partner violence
Keywords: اینترلوکین 6 (IL-6); C-reactive protein (CRP); Interleukin-6 (IL-6); Intimate partner violence (IPV); Oral mucosal transudate (OMT); Plasma; Saliva; Soluble interleukin-6 receptor (sIL-6R)
Tumor-produced, active Interleukin-1 β regulates gene expression in carcinoma-associated fibroblasts
Keywords: اینترلوکین 6 (IL-6); BDNF; brain-derived neurotrophic factor; CAFs; carcinoma-associated fibroblasts; DEX; dexamethasone; EMT; epithelial-mesenchymal transition; HNSCC; head and neck squamous cell carcinoma; IL1-β; interleukin-1 beta; IRAK-1; interleukin-1 receptor-associa
Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis
Keywords: اینترلوکین 6 (IL-6); Procalcitonin (PCT); Interleukin-6 (IL-6); C-reactive protein (CRP); Outcome; Multiple organ dysfunction
Correlation of a multi-cytokine panel with clinical disease activity in patients with rheumatoid arthritis
Keywords: اینترلوکین 6 (IL-6); Rheumatoid arthritis; Cytokine; Interleukin-6 (IL-6); Interferon-γ (IFN-γ); Health Assessment Questionnaire (HAQ); Standard 28-joint Disease Activity Score (DAS28); DMARD; Infliximab; Etanercept; Adalimumab
NF-κB inhibitory action of resveratrol: A probable mechanism of neuroprotection in experimental diabetic neuropathy
Keywords: اینترلوکین 6 (IL-6); Inflammatory mediators; Nuclear factor kappa B (NF-κB); Inhibitory kappa B (IκB-α); Cyclooxygenase 2 (COX-2); Diabetic neuropathy (DN); Tissue necrosis factor-α (TNF-α); Interleukin-6 (IL-6); Malondialdehyde (MDA)